Tohoku ChemicalTOHOKU CHEMICAL CO., LTD.7446東証スタンダード卸売業FY ending Sep 2025, consolidated, J-GAAP
About 50% of Tohoku Chemical's sales come from Pharmaceutical products, with Reagent for clinical test and Food making up much of the rest.
Out of every ¥100 of sales, about ¥2 is left as operating profit.
Revenue changed +16.7% from the prior year, operating profit +97.5%.
Revenue +16.7% · profit +97.5%, calculated from disclosed figures.
Operating leverage: 5.84× (profit growth ÷ revenue growth)
FY ending Sep 2020 → FY ending Sep 2021
FY ending Sep 2020 → FY ending Sep 2021
For every ¥100 Tohoku Chemical sells, how much goes where, and how much is kept.
Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.
Revenue by business segment, and the profit each one keeps.
※ Segments without disclosed profit are drawn entirely as costs
※ Segment figures include inter-segment sales and do not sum to the company total
EDINET (FSA Japan)
有価証券報告書－第74期(2024/10/01－2025/09/30)
EDINET (FSA Japan)
有価証券報告書－第73期(2023/10/01－2024/09/30)
EDINET (FSA Japan)
有価証券報告書－第72期(2022/10/01－2023/09/30)
EDINET (FSA Japan)
訂正有価証券報告書－第71期(2021/10/01－2022/09/30)
EDINET (FSA Japan)
有価証券報告書
EDINET (FSA Japan)
有価証券報告書－第69期(令和1年10月1日－令和2年9月30日)
Extracted from XBRL: 53 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.